Ignite Creation Date:
2024-05-05 @ 10:01 PM
Last Modification Date:
2024-10-26 @ 10:13 AM
Study NCT ID:
NCT01018069
Status:
TERMINATED
Last Update Posted:
2011-07-13
First Post:
2009-11-19
Brief Title:
AEG35156 in Combination With High-dose Cytarabine and Idarubicin in AML Following Failure of a Single Standard Dose Cytarabine Based Frontline Induction Regimen
Sponsor:
Aegera Therapeutics
Organization:
Aegera Therapeutics
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-11
Start Date Type:
None
Primary Completion Date:
2010-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-10
Completion Date Type:
ACTUAL
First Submit Date:
2009-11-19
First Submit QC Date:
November 20 2009
Study First Post Date:
2009-11-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2011-07-12
Last Update Post Date:
2011-07-13
Last Update Post Date Type:
ESTIMATED